2013
DOI: 10.13179/canchemtrans.2013.01.02.0017
|View full text |Cite
|
Sign up to set email alerts
|

Survey of Anti-HIV and Anti-HCV Compounds from Natural Sources

Abstract: This review article describes our recent research on (from 2005 to the end of 2012) isolation and identification of natural products, their in vivo metabolites and synthesized derivatives as potential anti-viral agents. Bioactivity assays focused on the inhibition of essential viral enzymes such as HIV protease, HCV protease, and -glucosidase. Bioactive compounds were structurally classified as lignans, triterpenes, chlorogenic acid derivatives and farnesyl hydroquinones. The possible mechanisms of inhibition… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 44 publications
(71 reference statements)
0
2
0
Order By: Relevance
“…Other authors have focused on the structural modification of chlorogenic acid in order to potentiate its anti-HIV properties through the inhibition of the α-glucosidase. Besides the role of the inhibitors of α-glucosidase in the progression of diabetes by decreasing carbohydrate digestion and absorption, in recent years, the inhibition of α-glucosidase has been considered a promising strategy for the development of novel anti-HIV agents due to the glycosylation of viral envelope glycoproteins [30]. The envelope glycoproteins gp120 and gp41 play crucial roles in HIV entry, thus serving as key targets for the development of HIV entry inhibitors [31].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Other authors have focused on the structural modification of chlorogenic acid in order to potentiate its anti-HIV properties through the inhibition of the α-glucosidase. Besides the role of the inhibitors of α-glucosidase in the progression of diabetes by decreasing carbohydrate digestion and absorption, in recent years, the inhibition of α-glucosidase has been considered a promising strategy for the development of novel anti-HIV agents due to the glycosylation of viral envelope glycoproteins [30]. The envelope glycoproteins gp120 and gp41 play crucial roles in HIV entry, thus serving as key targets for the development of HIV entry inhibitors [31].…”
Section: Discussionmentioning
confidence: 99%
“…Inhibitors of α-glucosidases can cause glycoproteins to misfolded and remain within the endoplasmic reticulum, interfering with the viral life cycle and infectious process [32]. Thus, Hattori et al [30] proposed the utilization of novel α-glucosidase inhibitors through the optimization of the hydrophilicity of chlorogenic acid by addition of alkyl chains of various lengths. The addition of ketal or acetal bonds to chlorogenic acid derivatives caused an increase in the inhibitory activity of 1 α-glucosidases.…”
Section: Discussionmentioning
confidence: 99%